Sign in
4

Changes in Ownership

BECTON DICKINSON & CO Filed Acc 0001628280-25-054855

EVP, CRO & Pres. Life Sciences sold 75 shares at $193.36 ($14,502)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Feld Michael · EVP, CRO & Pres. Life Sciences

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-01 Sale : show line 1 in the form 10b5-1 −75 $193.36 $14,502 16,580 D
Open-market sales · 75 sh · avg $193.36 · $14,502
Loading xslF345X05/wk-form4_1764717914.xml…